# Error Analysis

## Objective

The objective of this analysis is to evaluate the prediction performance of the proposed Adaptive Neural Network on the Chronic Kidney Disease (CKD) dataset and investigate any misclassified samples.

## Methodology

The trained model was evaluated using the held-out test dataset. Predicted labels were compared with the actual class labels to identify:

- False Positives (FP)
- False Negatives (FN)

The confusion matrix and classification metrics were used to assess the model performance.

## Results

- Total Test Samples: 80
- False Positives: 0
- False Negatives: 0

## Observations

The Adaptive Neural Network achieved perfect classification on the CKD test dataset.

The confusion matrix was:

```
[[50  0]
 [ 0 30]]
```

No False Positives or False Negatives were observed. Therefore, no misclassified patient profiles were available for further error analysis.

## Discussion

Although no prediction errors occurred in this experiment, misclassifications may occur in larger or more diverse clinical datasets due to:

- Early-stage CKD with subtle clinical symptoms.
- Borderline laboratory measurements.
- Missing or noisy clinical data.
- Overlapping characteristics between CKD and non-CKD patients.

## Clinical Significance

Accurate identification of CKD patients is important because delayed diagnosis can lead to disease progression and reduced treatment effectiveness.

The model achieved excellent sensitivity and specificity on the current dataset, making it suitable for CKD prediction under the evaluated conditions.

## Conclusion

The proposed Adaptive Neural Network demonstrated excellent generalization performance on the CKD dataset. All test samples were classified correctly, resulting in perfect accuracy, precision, recall, and F1-score. Future work should evaluate the model on larger and more diverse clinical datasets to further validate its robustness and real-world applicability.